Leveraging modular gene editors and new regulatory pathways, Aurora will develop and commercialize therapies that can be rapidly tailored to many rare variants -- Founded by CRISPR pioneers Jennifer ...

Corporate presentation at 7:30 AM PST on January 15 in room Elizabethan A at the Westin St. Frances hotel, San Francisco ...

The gene therapy success with Baby KJ, along with a new FDA program, have companies more interested in treating rare disease.

Victoria Gray spent 34 years battling the debilitating pain of sickle cell disease. Then she volunteered to be the world's first "prototype" for a CRISPR therapy, based on technology invented at UC ...

Across all domains of life, immune defenses foil invading viruses by making it impossible for the viruses to replicate. Most ...

Across all domains of life, immune defenses foil invading viruses by making it impossible for the viruses to replicate. Most known CRISPR systems target invading pathogens' DNA and chop it up to ...

Across all domains of life, immune defenses foil invading viruses by making it impossible for the viruses to replicate. Most ...

RNA drugs are a new type of medicine that treat disease by influencing how cells use genetic information, rather than by ...

Cell-surface proteins are critical therapeutic targets and are vital to cellular communication, signaling, and homeostasis.

CHANGE-seq-BE was developed to enable scientists to better understand base editors, an important class of CRISPR precise genome editors.

Innovative research into the gene-editing tool targets influenza’s ability to replicate—stopping it in its tracks.